Pulmonary cavitary sarcoidosis: Clinico-radiologic characteristics and natural history of a rare form of sarcoidosis

Medicine

Volumn 87, Issue 3, 2008, Pages 142-151

  Hours, Sandrine ^b   Nunes, Hilario ^a,b,c   Kambouchner, Marianne ^b   Uzunhan, Yurdagül ^a,b   Brauner, Michel W ^a,b   Valeyre, Dominique ^a,b   Brillet, Pierre Yves ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AIRWAY OBSTRUCTION; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HUMAN; HUMAN TISSUE; INFECTIOUS COMPLICATION; LUNG ASPERGILLOSIS; LUNG CAVITATION; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG HEMORRHAGE; LUNG SARCOIDOSIS; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM XENOPEI; PNEUMOTHORAX; PREVALENCE; PRIORITY JOURNAL; RARE DISEASE; RETROSPECTIVE STUDY; REVIEW; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

ADULT; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 44449140373     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181775a73     Document Type: Review

References (45)

1. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol. 2000;174:1751-1757.
2. Aberle DR, Gamsu G, Lynch D. Thoracic manifestations of Wegener granulomatosis: diagnosis and course. Radiology. 1990;174:703-709.
3. Akelsson IG, Eklund A, Skold CM, Tornling G. Bilateral spontaneous pneumothorax and sarcoidosis. Sarcoidosis. 1990;7:136-138.
4. Bistrong HW, Tenney RD, Sheffer AL. Asymptomatic cavitary sarcoidosis. JAMA. 1970;213:1030-1032.
5. Brauner MW, Lenoir S, Grenier P, Cluzel P, Battesti JP, Valeyre D. Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology. 1992;182:349-354.
6. Brauner MW, Grenier P, Mompoint D, Lenoir S, de Cremoux H. Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology. 1989;172:467-471.
7. Churg A, Dai J, Tai H, Wright JL. Tumor necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med. 2002;166:849-854.
8. Churg A, Carrington CB, Gupta R. Necrotizing sarcoid granulomatosis. Chest. 1979;76:406-413.
9. Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J. 1994;7:624-627.
10. Dorcier F, Grenier N, Dubroca J, Lacoste D, Beylot J, Grelet P. Thoracic sarcoidosis with pulmonary cavitation. Apropos of a case. J Radiol. 1987;68:451-454.
11. Edelman RR, Johnson TS, Jhaveri HS, Kim D, Kasdon E, Frank HA, Simon M. Fatal hemoptysis resulting from erosion of a pulmonary artery in cavitary sarcoidosis. AJR Am J Roentgenol. 1985;145:37-38.
12. Fehrenbach H, Zissel G, Goldmann T, Tschernig T, Vollmer E, Pabst R, et al. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur Respir J. 2003;21:421-428.
13. Flora G, Dostanic D, Jakovic R, Sharma OP. Pneumothorax in sarcoidosis. Sarcoidosis. 1991;8:75-79.
14. Frazier AA, Rosado-de-Christenson ML, Galvin JR, Fleming MV. Pulmonary angiitis and granulomatosis: radiologic-pathologic correlation. Radiographics. 1998;18:687-710.
15. Freundlich IM, Libshitz HI, Glassman LM, Israel HL. Sarcoidosis. Typical and atypical thoracic manifestations and complications. Clin Radiol. 1970;21:376-383.
16. Froudarakis ME, Bouros D, Voloudaki A, Papiris S, Kottakis Y, Constantopoulos SH, Siafakas NM. Pneumothorax as a first manifestation of sarcoidosis. Chest. 1997;112:278-280.
17. Hamilton R, Petty TL, Haiby G. Cavitary sarcoidosis of the lung. Arch Intern Med. 1965;116:428-430.
18. Hamper UM, Fishman EK, Khouri NF, Johns CJ, Wang KP, Siegelman SS. Typical and atypical CT manifestations of pulmonary sarcoidosis. J Comput Assist Tomogr. 1986;10:928-936.
19. Harada T, Amano T, Takahashi A, et al. Necrotizing sarcoid granulomatosis presenting with elevated serum soluble interleukin-2 receptor levels. Respiration. 2002;69:468-470.
20. Ichikawa Y, Fujimoto K, Shiraishi T, Oizumi K. Primary cavitary sarcoidosis: high-resolution CT findings. AJR Am J Roentgenol. 1994;163:745.
21. Israel HL, Lenchner GS, Atkinson GW. Sarcoidosis and aspergilloma. The role of surgery. Chest. 1982;82:430-432.
22. Jaffe CC. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol. 2006;24:3245-3251.
23. Lachkar S, Dominique S, Thiberville L, Nouvet G, Genevois A. Aspergillosis and sarcoidosis. Rev Mal Respir. 2007;24:943-953.
24. Lee KW, Chung SY, Yang I, Lee Y, Ko EY, Park MJ. Correlation of aging and smoking with air trapping at thin-section CT of the lung in asymptomatic subjects. Radiology. 2000;214:831-836.
25. Lemay V, Carette MF, Parrot A, et al. Hemoptysis in sarcoidosis. Apropos of 6 cases including 4 with fatal outcome. Rev Pneumol Clin. 1995;51:61-70.
26. Leung AN, Brauner MW, Caillat-Vigneron N, Valeyre D, Grenier P. Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay. J Comput Assist Tomogr. 1998;22:229-234.
27. Maskell GF, Lockwood CM, Flower CD. Computed tomography of the lung in Wegener's granulomatosis. Clin Radiol. 1993;48:377-380.
28. Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med. 1963;35:67-89.
29. Mihaescu TT, Veres L. Pneumothorax and pulmonary cavitation in a man with systemic sarcoidosis. Sarcoidosis. 1990;7:129-132.
30. Ozseker ZF, Yilmaz A, Bayramgurler B, Guneylioglu D. Cavitary sarcoidosis: analysis of two cases. Respirology. 2002;7:289-291.
31. Piaton E, Rafii H, Aoun C, Saugier B, Brune J. Spontaneous pneumothorax disclosing pulmonary sarcoidosis. Presse Med. 1995;24:1621.
32. Quaden C, Tillie-Leblond I, Delobbe A, et al. Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations. Eur Respir J. 2005;26:778-785.
33. Rockoff SD, Rohatgi PK. Unusual manifestations of thoracic sarcoidosis. AJR Am J Roentgenol. 1985;144:513-528.
34. Rohatgi PK, Schwab LE. Primary acute pulmonary cavitation in sarcoidosis. AJR Am J Roentgenol. 1980;134:1199-1203.
35. Rosen Y, Moon S, Huang CT, Gourin A, Lyons HA. Granulomatous pulmonary angiitis in sarcoidosis. Arch Pathol Lab Med. 1977;101:170-174.
36. Ryu JH, Swensen SJ. Cystic and cavitary lung diseases: focal and diffuse. Mayo Clinic Proc. 2003;78:744-752.
37. Schiffner RO, Sharma OP. Acute pulmonary cavitation in sarcoidosis. West J Med. 1977;127:346-349.
38. Staples CA. Pulmonary angiitis and granulomatosis. Radiol Clin North Am. 1991;29:973-982.
39. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-755.
40. Takemura T, Matsui Y, Saiki S, Mikami R. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Pathol. 1992;23:1216-1223.
41. Tazi A, Desfemmes-Baleyte T, Soler P, Valeyre D, Hance AJ, Battesti JP. Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph. Thorax. 1994;49:793-797.
42. Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest. 1987;92:505-508.
43. Tuddenham WJ. Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society. AJR Am J Roentgenol. 1984;143:509-517.
44. Wollschlager C, Khan F. Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. Chest. 1984;86:585-588.
45. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Muller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sil-2r are prognostic markers. Am J Respir Crit Care Med. 1997;156:1586-1592.